Ikarian Capital »

Pmv Pharmaceuticals shares owned by Ikarian Capital

Quarter-by-quarter ownership of Pmv Pharmaceuticals (PMVP) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Pmv Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Pmv Pharmaceuticals held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Pmv Pharmaceuticals by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $137k 98k 1.40
2022-03-31 $4.2M 200k 20.82

More positions owned by Ikarian Capital

United Therapeutics Corporation Put Option (UTHR)
Spdr Series Trust S&p Biotech Put Option (XBI)
Genmab A/s Sponsored Ads (GMAB)
Bristol Myers Squibb Put Option (BMY)
Abivax Sa Sponsored Ads (ABVX)
Uniqure Nv Call Call Option
Insmed Com Par $.01 (INSM)
Ptc Therapeutics I (PTCT)
Ionis Pharmaceuticals (IONS)
Cidara Therapeutics Com New (CDTX)
Scholar Rock Hldg Corp Put Option (SRRK)
Rapt Therapeutics Com New (RAPT)
Maze Therapeatics (MAZE)
Soleno Therapeutics (SLNO)
Cytokinetics Com New (CYTK)

View all positions for Ikarian Capital

Top funds holding Pmv Pharmaceuticals

OrbiMed Advisors
BML Capital Management
Tang Capital Management
Arrowpoint Asset Management
Sio Capital Management
Euclidean Capital
Vanguard Group
Acadian Asset Management
Stonepine Capital Management
BlackRock
Marshall Wace
Aldebaran Capital
Geode Capital Management
Two Sigma Advisers
Jane Street

View all funds holding Pmv Pharmaceuticals